Condition: Epidermolysis Bullosa Simplex · Genodermatosis · Sponsor: Centre Hospitalier Universitaire de Nice
The goal of this clinical trial is to Assessing the Efficacy and Safety of Apremilast in Patients \> 6 years of age with EB simplex generalized . The main question it aims to answer are: describe efficacity of this treatment. Participants will take treatments and have to use bullets during the study period.
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| CHU de Nice | Nice, France, France | Recruiting |
| APHP Necker-Enfants-Malades | Paris, France, France | Not Yet Recruiting |
| APHP Hôpital Saint-Louis | Paris, France, France | Not Yet Recruiting |
| chu de Toulouse | Toulouse, France | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06509984